granisetron has been researched along with Hematologic Malignancies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cabanillas Stanchi, KM; Döring, M; Flaadt, T; Handgretinger, R; Lang, P; Michaelis, S; Rupprecht, JV; Schlegel, P; Vek, J; Weber, S | 1 |
| Akashi, K; Egashira, N; Hiraiwa, H; Ichinose, K; Ikesue, H; Iwasaki, H; Kato, K; Miyamoto, T; Muta, T; Oishi, R; Sakurai, A; Shiratsuchi, M; Suetsugu, K; Takenaka, K; Teshima, T; Uchida, M | 1 |
| Hori, K; Kawakami, J; Motohashi, S; Ohnishi, K; Ono, T | 1 |
| Akashi, K; Egashira, N; Hiraiwa, H; Ichinose, K; Ikesue, H; Iwasaki, H; Kato, K; Miyamoto, T; Oishi, R; Sakurai, A; Takenaka, K; Teshima, T; Uchida, M | 1 |
| Moriguchi, T; Tsudo, M | 1 |
| Miyata, Y; Saito, M; Takeyama, H; Yamada, H; Yamamoto, Y | 1 |
| Masaoka, T; Tatsumi, N | 1 |
3 trial(s) available for granisetron and Hematologic Malignancies
| Article | Year |
|---|---|
[Efficacy and safety of two methods of administration of granisetron injection for nausea and vomiting induced by chemotherapy for tumors in hematopoietic organs--a randomized crossover comparison between intravenous drip infusion and intravenous bolus in
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nausea; Vomiting | 1998 |
[Efficacy of granisetron in the prevention of emesis induced by conditioning chemotherapy for allogeneic bone marrow transplantation].
Topics: Adolescent; Adult; Antiemetics; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Female; Granisetron; Hematologic Neoplasms; Humans; Male; Middle Aged; Transplantation Conditioning; Vomiting; Whole-Body Irradiation | 1998 |
A comparative study of administration methods of granisetron injection used to treat nausea/vomiting induced by cancer chemotherapy without cisplatin in tumors of hematopoietic organs. Keihanshin Study Group of Hematological Malignancies.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nausea; Treatment Outcome; Vomiting | 1999 |
4 other study(ies) available for granisetron and Hematologic Malignancies
| Article | Year |
|---|---|
Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Granisetron; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Morpholines; Nausea; Transplantation Conditioning; Vomiting | 2020 |
Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Asian People; Female; Granisetron; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Retrospective Studies; Treatment Outcome; Vomiting; Young Adult | 2013 |
[Comparison of 1 mg/body and 3 mg/body of intravenous granisetron for the prevention of chemotherapy-induced nausea and vomiting and adverse events in hematological malignancy patients].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Dose-Response Relationship, Drug; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Retrospective Studies; Serotonin Antagonists; Vomiting | 2012 |
Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Drug Therapy, Combination; Female; Granisetron; Hematologic Neoplasms; Hospitals, University; Humans; Male; Middle Aged; Morpholines; Nausea; Retrospective Studies; Treatment Outcome; Vomiting; Young Adult | 2013 |